Pooled analyses of randomized controlled trials on pyrotinib plus capecitabine and a rethink of the first‐line options for HER2‐positive relapsed or metastatic breast cancer by Xiuwen Guan, Fei Ma, Binghe Xu

Get full text

Fabrication and Characterization of Chitosan/Poly(Lactic-Co-glycolic Acid) Core-Shell Nanoparticles by Coaxial Electrospray Technology for Dual Delivery of Natamycin and Clotrimazo... by Xiaoming Cui, Xiaoli Li, Zhilu Xu, Xiuwen Guan, Xiuwen Guan, Xiuwen Guan, Jinlong Ma, Jinlong Ma, Jinlong Ma, Dejun Ding, Dejun Ding, Dejun Ding, Weifen Zhang, Weifen Zhang, Weifen Zhang

Get full text

Recent advances in selective photothermal therapy of tumor by Liping Zhao, Xu Zhang, Xiaoxia Wang, Xiuwen Guan, Weifeng Zhang, Jinlong Ma

Get full text

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study by Zongbi Yi, Fei Ma, Binliang Liu, Xiuwen Guan, Lixi Li, Chunxiao Li, Haili Qian, Binghe Xu

Get full text

Antibody-drug conjugates in HER2-positive breast cancer by Lixi Li, Di Zhang, Binliang Liu, Dan Lv, Jingtong Zhai, Xiuwen Guan, Zongbi Yi, Fei Ma, Ningning Wang

Get full text

Pyrotinib plus capecitabine could significantly improve overall survival in HER2-positive metastatic breast cancer by Xiuwen Guan, Fei Ma, Qiao Li, Shanshan Chen, Ying Fan, Jiayu Wang, Yang Luo, Pin Zhang, Qing Li, Binghe Xu

Get full text

Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer by Hongnan Mo, Xiaobing Wang, Fei Ma, Ziliang Qian, Xiaoying Sun, Zongbi Yi, Xiuwen Guan, Lixi Li, Binliang Liu, Binghe Xu

Get full text

Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studi... by Xiuwen Guan, Fei Ma, Qiao Li, Shanshan Chen, Bo Lan, Ying Fan, Jiayu Wang, Yang Luo, Ruigang Cai, Pin Zhang, Qing Li, Binghe Xu

Get full text

Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis by Zongbi Yi, Fei Ma, Chunxiao Li, Rongrong Chen, Lifang Yuan, Xiaoying Sun, Xiuwen Guan, Lixi Li, Binliang Liu, Yanfang Guan, Haili Qian, Binghe Xu

Get full text

Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study by Jiani Wang, Yuwei Liu, Renzhi Zhang, Zhenyu Liu, Zongbi Yi, Xiuwen Guan, Xinming Zhao, Jingying Jiang, Jie Tian, Fei Ma, Rongman Jia, Xiuyuan Hao

Get full text

Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage by Xiuwen Guan, Fei Ma, Fei Ma, Xiaoying Sun, Chunxiao Li, Lixi Li, Fang Liang, Shaochuan Li, Zongbi Yi, Binliang Liu, Binghe Xu, Binghe Xu

Get full text

Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer by Xiuwen Guan, Binliang Liu, Yunyun Niu, Xin Dong, Xia Zhu, Chunxiao Li, Lixi Li, Zongbi Yi, Xiaoying Sun, Hongyan Chen, Sijia Lu, Fei Ma

Get full text

The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymor... by Binliang Liu, Tao An, Meiying Li, Zongbi Yi, Chunxiao Li, Xiaoying Sun, Xiuwen Guan, Lixi Li, Yanfeng Wang, Yuhui Zhang, Binghe Xu, Fei Ma, Yixin Zeng

Get full text

Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers by Zongbi Yi, Binliang Liu, Xiaoying Sun, Guohua Rong, Wenna Wang, Hui Li, Xiuwen Guan, Lixi Li, Jingtong Zhai, Chunxiao Li, Haili Qian, Fei Ma, Binghe Xu

Get full text

The molecular tumor burden index as a response evaluation criterion in breast cancer by Zongbi Yi, Fei Ma, Guohua Rong, Binliang Liu, Yanfang Guan, Jin Li, Xiaoying Sun, Wenna Wang, Xiuwen Guan, Hongnan Mo, Jiani Wang, Haili Qian, Binghe Xu

Get full text

Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer by Xiuwen Guan, Chunxiao Li, Yiqun Li, Jiani Wang, Zongbi Yi, Binliang Liu, Hongyan Chen, Jiasen Xu, Haili Qian, Binghe Xu, Binghe Xu, Fei Ma, Fei Ma

Get full text

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER‐targeted therapy in HER2 amplification‐positive and HER2 mutation‐positi... by Binliang Liu, Zongbi Yi, Yanfang Guan, Quchang Ouyang, Chunxiao Li, Xiuwen Guan, Dan Lv, Lixi Li, Jingtong Zhai, Haili Qian, Binghe Xu, Fei Ma, Yixin Zeng

Get full text

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer by Shaoyan Lin, Jian Yue, Xiuwen Guan, Peng Yuan, Jiayu Wang, Yang Luo, Ying Fan, Ruigang Cai, Qiao Li, Shanshan Chen, Pin Zhang, Qing Li, Fei Ma, Binghe Xu

Get full text

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first-line chemotherapy of HER2-... by Xiuwen Guan, Fei Ma, Chunxiao Li, Shiyang Wu, Shangying Hu, Jiefen Huang, Xiaoying Sun, Jiayu Wang, Yang Luo, Ruigang Cai, Ying Fan, Qiao Li, Shanshan Chen, Pin Zhang, Qing Li, Binghe Xu

Get full text

Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China by Shaoyan Lin, Hongnan Mo, Yiqun Li, Xiuwen Guan, Yimeng Chen, Zijing Wang, Peng Yuan, Jiayu Wang, Yang Luo, Ying Fan, Ruigang Cai, Qiao Li, Shanshan Chen, Pin Zhang, Qing Li, Fei Ma, Binghe Xu

Get full text